Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q4 EPS of ($1.91).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- Rain Enhancement Technologies signs fog-testing deal with CHP
- Snowflake (SNOW) call put ratio 1.3 calls to 1 put into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
